DexCom
DXCM
797 hedge funds and large institutions have $51.3B invested in DexCom in 2021 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 283 increasing their positions, 275 reducing their positions, and 41 closing their positions.
185% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 41
88% more funds holding in top 10
Funds holding in top 10: 8 → 15 (+7)
27% more capital invested
Capital invested by funds: $40.5B → $51.3B (+$10.8B)
12% more call options, than puts
Call options by funds: $1.11B | Put options by funds: $983M
9% more funds holding
Funds holding: 728 → 797 (+69)
3% more repeat investments, than reductions
Existing positions increased: 283 | Existing positions reduced: 275
4.67% less ownership
Funds ownership: 392.37% → 387.7% (-4.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$199M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$145M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$134M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$128M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$125M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$456M |
| 2 |
JP Morgan Chase
New York
|
-$381M |
| 3 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$215M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$129M |
| 5 |
Janus Henderson Group
London,
|
-$128M |
DXCM Hedge Fund Activity: Q3 2021 in Review
797 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q3 2021, worth a combined $51.3B — up 27% from $40.5B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new DXCM positions and 41 closed out — a net gain of 76 holders — while 283 added to existing stakes and 275 trimmed.
The largest buyer was Lord, Abbett & Co, adding an estimated $199M. The largest seller was Morgan Stanley, cutting an estimated $456M.
- 797 institutional investors held DexCom (DXCM) as of Q3 2021, up from 728 in Q2 2021.
- Funds reported $51.3B of DexCom stock for Q3 2021, up 27% quarter-over-quarter.
- 117 funds opened new DexCom positions in Q3 2021 and 41 closed out, a net change of +76 holders.
- The largest DexCom buyer in Q3 2021 was Lord, Abbett & Co, an estimated $199M added.
- The largest DexCom seller in Q3 2021 was Morgan Stanley, an estimated $456M sold.
Based on aggregated 13F filings for Q3 2021.